Point-of-care bone cement based on natural peptide comonomer protects orthopaedic implants from bacterial challenge
Open Access
- 7 October 2025
- journal article
- Published by Elsevier in Materials Today Bio
- Vol. 35, 102388
Abstract
No abstract availableKeywords
Funding Information
- Anhui Provincial Natural Science Foundation (2308085QB47)
- National Natural Science Foundation of China (22507036)
- Shenzhen Science and Technology Innovation Program (SGDX20201103095600002)
This publication has 66 references indexed in Scilit:
- Antibiotic TMA (Therapeutic Methacrylic) Comonomers: Synergizing Mechanical Integrity with Infection Control in Bone CementAdvanced Functional Materials, 2024
- Periprosthetic Joint Infection After Total Knee Arthroplasty With or Without Antibiotic Bone CementJAMA Network Open, 2024
- Hierarchical antibiotic delivery system based on calcium phosphate cement/montmorillonite-gentamicin sulfate with drug release pathwaysColloids and Surfaces B: Biointerfaces, 2024
- Bioactive strong biodegradable bone cement for rapid osteointegration and osteogenesisChemical Engineering Journal, 2023
- The use of bacterial polysaccharides in bioprintingBiotechnology Advances, 2019
- Are We Winning or Losing the Battle With Periprosthetic Joint Infection: Trends in Periprosthetic Joint Infection and Mortality Risk for the Medicare PopulationThe Journal of Arthroplasty, 2018
- Nano-carrier based drug delivery systems for sustained antimicrobial agent release from orthopaedic cementous materialAdvances in Colloid and Interface Science, 2017
- Towards the optimization of the preparation procedures of PMMA bone cementJournal of Orthopaedic Research, 2015
- Formulation and characterization of antimicrobial quaternary ammonium dendrimer in poly(methyl methcarylate) bone cementJournal of Biomedical Materials Research Part B: Applied Biomaterials, 2015
- Surface functional group dependence on apatite formation on self-assembled monolayers in a simulated body fluidJournal of Biomedical Materials Research, 1997